基于社会人口学特征的BCG膀胱癌治疗数学建模
Mathematical Modeling of BCG-based Bladder Cancer Treatment Using Socio-Demographics
AI总结:
本研究利用患者社会人口学特征,通过集成机器学习组件动态调整BCG治疗模型的关键参数,提出个性化数学模型,在预测治疗结束时癌细胞数量上平均提升14.8%。
摘要:
癌症是全球最普遍的疾病之一,每年新增数百万患者。膀胱癌是最常见的癌症类型之一,对所有人群的影响相似,没有明显的典型患者。目前膀胱癌的标准治疗方案遵循常规的每周一次卡介苗(BCG)免疫治疗协议,并同等应用于所有患者。由于免疫系统、治疗和癌细胞之间相互作用的生物学和临床复杂性,BCG治疗相关的临床结果在患者间差异显著。在本研究中,我们利用患者的社会人口学特征,提出一个个性化数学模型来描述BCG治疗的临床动态。为此,我们采用成熟的BCG治疗模型,并集成机器学习组件以临时调整和重新配置模型中的关键参数,从而促进其个性化。使用真实临床数据,我们表明个性化模型在预测治疗结束时的癌细胞数量方面优于原始模型,平均提升了14.8%。
英文摘要:
Cancer is one of the most widespread diseases around the world with millions of new patients each year. Bladder cancer is one of the most prevalent types of cancer affecting all individuals alike with no obvious prototypical patient. The current standard treatment for BC follows a routine weekly Bacillus Calmette-Guerin (BCG) immunotherapy-based therapy protocol which is applied to all patients alike. The clinical outcomes associated with BCG treatment vary significantly among patients due to the biological and clinical complexity of the interaction between the immune system, treatments, and cancer cells. In this study, we take advantage of the patient's socio-demographics to offer a personalized mathematical model that describes the clinical dynamics associated with BCG-based treatment. To this end, we adopt a well-established BCG treatment model and integrate a machine learning component to temporally adjust and reconfigure key parameters within the model thus promoting its personalization. Using real clinical data, we show that our personalized model favorably compares with the original one in predicting the number of cancer cells at the end of the treatment, with 14.8% improvement, on average.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。